UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 14.035

Sortiert nach

The multi-factorial nature of clinical multidrug resistance in cancer

Drug resistance updates, 2019-09, Vol.46, p.100645-100645, Article 100645

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer stem cells and chemoresistance: The smartest survives the raid

Pharmacology & therapeutics (Oxford), 2016-04, Vol.160, p.145-158

Zhao, Jihe

2016

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria and cancer chemoresistance

Biochimica et biophysica acta. Bioenergetics, 2017-08, Vol.1858 (8), p.686-699

2017

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer

Drug discovery today, 2019-10, Vol.24 (10), p.2058-2067

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic strategies to overcome taxane resistance in cancer

Drug resistance updates, 2021-03, Vol.55, p.100754, Article 100754

2021

Link zum Volltext

Verfügbarkeit prüfen

Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies

Drug resistance updates, 2016-07, Vol.27, p.14-29

2016

Link zum Volltext

Verfügbarkeit prüfen

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

Cancer cell, 2018-12, Vol.34 (6), p.893-905.e8

2018

Link zum Volltext

Verfügbarkeit prüfen

Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer

Biochemical pharmacology, 2019-04, Vol.162, p.169-176

2019

Link zum Volltext

Verfügbarkeit prüfen

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

Seminars in cancer biology, 2018-06, Vol.50, p.77-89

2018

Link zum Volltext

Verfügbarkeit prüfen

Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer

Carbohydrate polymers, 2021-02, Vol.254, p.117459, Article 117459

2021

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine resistance in pancreatic ductal adenocarcinoma

Drug resistance updates, 2015-11, Vol.23, p.55-68

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapy resistance mediated by cancer stem cells

Seminars in cancer biology, 2018-12, Vol.53, p.156-167

2018

Link zum Volltext

Verfügbarkeit prüfen

Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation

Molecular cell, 2021-03, Vol.81 (6), p.1216-1230.e9

2021

Link zum Volltext

Verfügbarkeit prüfen

BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition

Cancer cell, 2015-09, Vol.28 (3), p.370-383

2015

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

Cancer cell, 2019-10, Vol.36 (4), p.369-384.e13

2019

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting autophagy to prevent drug resistance and improve anti-tumor therapy

Life sciences (1973), 2021-01, Vol.265, p.118745, Article 118745

2021

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

European journal of pharmacology, 2014-10, Vol.741, p.8-16

2014

Link zum Volltext

Verfügbarkeit prüfen

Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach

Drug resistance updates, 2015-11, Vol.23, p.69-78

2015

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors

Seminars in oncology, 2015-12, Vol.42 (6), p.801-819

2015

Link zum Volltext

Verfügbarkeit prüfen

The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy

Biochemical and biophysical research communications, 2016-09, Vol.478 (3), p.1067-1073

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 14.035

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13.820)
Mit Volltextzugriff
(13.372)

Publikationsform

Artikel
(14.017)
Buchkapitel
(17)
Bücher
(1)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(13.145)
Science & Technology
(12.877)
Life Sciences & Biomedicine
(12.671)
Drug Resistance, Neoplasm
(5.481)
Oncology
(4.994)
Female
(4.792)
Animals
(4.257)
Cell Line, Tumor
(4.020)
Biological And Medical Sciences
(3.346)
Medical Sciences
(3.198)
Antineoplastic Agents - Pharmacology
(2.982)
Drug Resistance
(2.982)
Pharmacology & Pharmacy
(2.977)
Male
(2.824)
Drug Resistance, Neoplasm - Genetics
(2.204)
Hematology, Oncology And Palliative Medicine
(2.202)
Biochemistry & Molecular Biology
(2.192)
Drug Resistance, Neoplasm - Drug Effects
(2.156)
Antineoplastic Agents - Therapeutic Use
(2.084)
Mice
(2.056)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Letters
(1.164)
Biochemical And Biophysical Research Communications
(655)
Biochemical Pharmacology
(582)
European Journal Of Cancer
(480)
Leukemia Research
(419)
Gynecologic Oncology
(408)
Biomedicine & Pharmacotherapy
(376)
Lung Cancer
(333)
Drug Resistance Updates
(260)
Cancer Cell
(247)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(103)
... seit 30 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

The multi-factorial nature of clinical multidrug resistance in cancer

Cancer stem cells and chemoresistance: The smartest survives the raid

Mitochondria and cancer chemoresistance

Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer

Therapeutic strategies to overcome taxane resistance in cancer

Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance

Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Gemcitabine resistance in pancreatic ductal adenocarcinoma

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Therapy resistance mediated by cancer stem cells

Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation

BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

Inhibiting autophagy to prevent drug resistance and improve anti-tumor therapy

Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells

Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors

The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy

Aktive Filter

Suchergebnisse filtern